Categories AlphaGraphs, Earnings, Finance

Earnings preview: Here’s what to expect when American Express reports Q2 results

American Express Company (NYSE: AXP) is scheduled to report second quarter 2019 earnings results on Friday, July 19, before market open. The consensus estimate is for earnings of $2.03 per share on revenue of $10.82 billion. In the trailing four quarters, the company has topped earnings estimates three times.

The results in the second quarter are expected to be driven by higher cardmember spending, loan volumes and billings growth. Revenues are expected to benefit from higher member spending and fee income. New memberships and related income are also likely to help the topline numbers.

American Express reports first quarter 2019 earnings results

The credit card provider’s partnerships with other companies like Delta Air Lines (NYSE: DAL) are also likely to benefit revenues during the quarter. The growth in revenues will prove beneficial to the bottom line numbers. However higher expenses related to customer services are likely to put pressure on margins during the period.

In the first quarter of 2019, Amex beat earnings estimates but missed the mark on revenue. Revenue grew 7% year-over-year to $10.36 billion while adjusted EPS grew 8% to $2.01. The company saw revenue increases across all its segments.

For fiscal year 2019, Amex has guided for GAAP EPS to come in the range of $7.64-8.14 and adjusted EPS in the range of $7.85-8.35. The company expects revenue to grow 8-10% during the year.

American Express’ shares have gained 27% in the trailing 52 weeks and over 35% so far this year. The majority of analysts have rated the stock as Hold while others have rated it as Buy.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top